跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mabthera - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mabthera
Approved
STANDARD
Mabthera
F. Hoffman-La Roche AG.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
071196d22af99f7c
Company
F. Hoffman-La Roche AG.
Type
Standard
Approval Details
Approval Id
071196d22af99f7c
Drug Approval Philippines Name
Mabthera
Product Name
Mabthera
Registration Number
BR-1122
Brand Name
Mabthera
Generic Name
Rituximab
Dosage Form
Solution for Injection (SC)
Dosage Strength
1400 mg/11.7 mL
Manufacturer
F. Hoffman-La Roche AG.
Issuance Date
26 February 2025
Expiry Date
26 February 2030
Pharmacologic Category
Antineoplastic Agents
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
071196d22af99f7c
Type
Standard
Back to Philippines FDA Approvals